Inventor · disambiguated record
Euan Alexander Fraser Fordyce
Also filed as: FORDYCE EUAN · FORDYCE EUAN ALEXANDER FRASER · FORDYCE Euan Alexander
23 granted patents·5 pending applications·91 citations·filing 2013–2024
94Inventor score
Top patents by PatentIndex Score
28 records- 0197US9624196B2Inhibitor of p38 MAP kinaseRESPIVERT LTD·Filed 2016·Granted Apr 18, 2017·15 cites·5 claims
- 0296US9447076B2Inhibitor of p38 map kinaseRESPIVERT LTD·Filed 2015·Granted Sep 20, 2016·16 cites·18 claims
- 0395US9732098B25,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivativeHUNT SIMON FRASER·Filed 2015·Granted Aug 15, 2017·32 cites·13 claims
- 0489US10954241B2Heterocyclic compounds as ret kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2017·Granted Mar 23, 2021·3 cites·29 claims
- 0588US10844067B2Heterocyclic compounds as RET kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2017·Granted Nov 24, 2020·4 cites·27 claims
- 0687US11548896B2Heterocyclic compounds as RET kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2021·Granted Jan 10, 2023·1 cites·30 claims
- 0785US11661423B2Heterocyclic compounds as RET kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2020·Granted May 30, 2023·1 cites·24 claims
- 0885US2025236624A1Heterocyclic Compounds as RET Kinase InhibitorsCANCER RESEARCH TECH LTD·Filed 2024·Application pending·0 cites
- 0983US10294216B2Pyrazolyl ureas as kinase inhibitorsRESPIVERT LTD·Filed 2017·Granted May 21, 2019·1 cites·13 claims
- 1083US10189863B25,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivativesPULMOCIDE LTD·Filed 2015·Granted Jan 29, 2019·3 cites·24 claims
- 1183US9701670B2Pyrazolyl-ureas as kinase inhibitorsRESPIVERT LTD·Filed 2013·Granted Jul 11, 2017·10 cites·18 claims
- 1282US10035810B25,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivativePULMOCIDE LTD·Filed 2018·Granted Jul 31, 2018·2 cites·7 claims
- 1381US9926335B25,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivativeHUNT SIMON FRASER·Filed 2017·Granted Mar 27, 2018·2 cites·4 claims
- 1478US2023339954A1Heterocyclic Compounds as RET Kinase InhibitorsCANCER RESEARCH TECH LTD·Filed 2022·Application pending·0 cites
- 1576US11634406B2Inhibitor of p38 MAP kinaseRESPIVERT LTD·Filed 2020·Granted Apr 25, 2023·0 cites·10 claims
- 1676US11142515B2Pyrazolyl-ureas as kinase inhibitorsRESPIVERT LTD·Filed 2019·Granted Oct 12, 2021·0 cites·9 claims
- 1776US9884845B2Pyrazolyl-ureas as kinase inhibitorsRESPIVERT LTD·Filed 2015·Granted Feb 6, 2018·1 cites·17 claims
- 1876US2024116938A1Heterocyclic Compounds as RET Kinase InhibitorsCANCER RESEARCH TECH LTD·Filed 2023·Application pending·0 cites
- 1970US10815217B2Inhibitor of p38 MAP kinaseRESPIVERT LTD·Filed 2018·Granted Oct 27, 2020·0 cites·13 claims
- 2070US2025092023A1Piperazine indazole glucocorticoid receptor antagonistsCORCEPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2168US10472375B25,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivativePULMOCIDE LTD·Filed 2019·Granted Nov 12, 2019·0 cites·6 claims
- 2268US10273249B25,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivativePULMOCIDE LTD·Filed 2018·Granted Apr 30, 2019·0 cites·5 claims
- 2368US10045980B2Inhibitor of p38 map kinaseRESPIVERT LTD·Filed 2017·Granted Aug 14, 2018·0 cites·13 claims
- 2468US2024360099A1Nicotinamide ripk1 inhibitorsABBVIE INC·Filed 2024·Application pending·0 cites
- 2567US12098144B2Piperazine indazole glucocorticoid receptor antagonistsCORCEPT THERAPEUTICS INC·Filed 2022·Granted Sep 24, 2024·0 cites·28 claims
- 2667US11767310B2Nicotinamide RIPK1 inhibitorsABBVIE INC·Filed 2022·Granted Sep 26, 2023·0 cites·8 claims
- 2744US10626126B2CompoundsPULMOCIDE LTD·Filed 2017·Granted Apr 21, 2020·0 cites·20 claims
- 2836US10160772B25,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivativesPULMOCIDE LTD·Filed 2015·Granted Dec 25, 2018·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Euan Alexander Fraser Fordyce files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →